25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein.
about
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein.Variation in oral calcitriol response in patients with stages 3-4 CKD.The group-specific protein marker: a possible indicator of syphilis, not human immunodeficiency virus infection.Vitamin D binding protein sequesters monomeric actin in the circulation of the rat.Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver diseaseVitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo.Detection of genetic variation with radioactive ligands. II. Genetic variants of vitamin D-labeled group-specific component (Gc) proteinsRadioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasisImmunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serumExtraction of vitamin D metabolites by bones of normal adult dogs.Quantitative studies of the interaction of cholecalciferol ((vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols.Vitamin D plasma binding protein. Turnover and fate in the rabbit.Actin affinity chromatography in the purification of human, avian and other mammalian plasma proteins binding vitamin D and its metabolites (Gc globulins).Uptake and degradation of vitamin D binding protein and vitamin D binding protein-actin complex in vivo in the ratUptake and degradation of filamentous actin and vitamin D-binding protein in the rat.Chromatofocusing in the purification and separation of apo- and holo-(vitamin D-binding protein)Effect of ligand binding on the conformation of human plasma vitamin D binding protein (group-specific component).What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care.
P2860
Q30448781-63B66DAF-9DDD-441F-A7CD-AFFF4E14B320Q30513471-A820626C-21AF-42CA-9904-A0F291E93536Q34101585-EEB7D0B9-1C28-4CFE-B00D-953D50DE980AQ34571018-D1645F59-A3C0-4D70-AFE1-F1D0C69B580DQ34621374-4650723C-1D55-4CA6-B9E0-7770076E95CEQ34655991-4BA6CC55-975D-40F7-87FE-DF9E9E497587Q35202590-6101AE55-2F3F-4921-B91A-0BA5BF67B5F9Q35905179-0BEF1B9C-6815-4147-B838-4591C19A9867Q35905835-0EE4C3CF-C6C0-45A0-989F-64A633C50F5BQ37008793-9A12CCF3-66E6-4060-A6C3-54D40C2424EEQ39566496-D606ECCE-E58B-44ED-BDFB-C421C2279133Q40683517-908ECEE0-E161-4A0C-9D71-20DB55E435EEQ41810531-F0B4D3FC-A7C3-477E-ACFD-AFF7ADFB3F98Q41879046-82A5A392-7EBD-4314-9A51-5DE9D59CDB53Q42020286-D94392C7-BFE0-41C5-ABF6-CE550254B965Q42033007-F370BC56-76C6-4297-85AB-00C587616E87Q42881725-B839592C-9520-4966-BD0D-68ABD4ACFC80Q48248826-24979494-3D11-4197-BA26-B7B839C2CABC
P2860
25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh-hant
name
25-Hydroxyvitamin D transport ...... f calcifidiol-binding protein.
@en
25-Hydroxyvitamin D transport ...... f calcifidiol-binding protein.
@nl
type
label
25-Hydroxyvitamin D transport ...... f calcifidiol-binding protein.
@en
25-Hydroxyvitamin D transport ...... f calcifidiol-binding protein.
@nl
prefLabel
25-Hydroxyvitamin D transport ...... f calcifidiol-binding protein.
@en
25-Hydroxyvitamin D transport ...... f calcifidiol-binding protein.
@nl
P1476
25-Hydroxyvitamin D transport ...... of calcifidiol-binding protein
@en
P2093
Haddad JG Jr
P304
P407
P577
1976-08-01T00:00:00Z